Status:
COMPLETED
Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers
Lead Sponsor:
Abbott
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The objectives of this study are to determine the cerebrospinal fluid (CSF) levels of ABT-126 and to examine the effects of ABT-126 on exploratory biomarkers after administration of a single does of A...
Eligibility Criteria
Inclusion
- Healthy male or female subjects between 18 and 50 years of age
Exclusion
- History of bleeding disorders or Deep Vein Thrombosis
- History of spinal surgery
- History of migraine headaches, or other types of headaches occuring more than 2 times per month, or history of spinal disc disease, or chronic, significant low back pain
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00912431
Start Date
June 1 2009
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 20761
Glendale, California, United States, 91206